Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
CCL5 (Chemokine (C-C motif) ligand 5)
i
Other names:
CCL5, D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228, Chemokine (C-C motif) ligand 5
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
6352
Related tests:
‹
myPath Melanoma
myPath Melanoma
›
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
PD-L1 overexpression + CCL5 overexpression
Esophageal Squamous Cell Carcinoma
PD-L1 overexpression + CCL5 overexpression
Esophageal Squamous Cell Carcinoma
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
CCL5 overexpression
Small Cell Lung Cancer
CCL5 overexpression
Small Cell Lung Cancer
olaparib
Sensitive: C3 – Early Trials
olaparib
Sensitive
:
C3
olaparib
Sensitive: C3 – Early Trials
olaparib
Sensitive
:
C3
CCL5 overexpression
Small Cell Lung Cancer
CCL5 overexpression
Small Cell Lung Cancer
durvalumab
Sensitive: C3 – Early Trials
durvalumab
Sensitive
:
C3
durvalumab
Sensitive: C3 – Early Trials
durvalumab
Sensitive
:
C3
CCL5 elevation
Biliary Tract Cancer
CCL5 elevation
Biliary Tract Cancer
atezolizumab + cobimetinib
Sensitive: C3 – Early Trials
atezolizumab + cobimetinib
Sensitive
:
C3
atezolizumab + cobimetinib
Sensitive: C3 – Early Trials
atezolizumab + cobimetinib
Sensitive
:
C3
CCL5 overexpression
Glioblastoma
CCL5 overexpression
Glioblastoma
maraviroc
Sensitive: D – Preclinical
maraviroc
Sensitive
:
D
maraviroc
Sensitive: D – Preclinical
maraviroc
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.